CLLS Articles, Cellectis S.A.
home / stock / clls / clls articles
No one has written and article on Cellectis S.A., stock symbol CLLS. Be the first to contribute and write an article.
Cellectis S.A. Company Name:
CLLS Stock Symbol:
NASDAQ Market:
News, Short Squeeze, Breakout and More Instantly...
-
NEW YORK, May 23, 2022 (GLOBE NEWSWIRE) -- Cellectis (Euronext Growth: ALCLS; Nasdaq: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, announced today that it will hold its combined general meeting on Ju...
-
Shares of Cellectics (NASDAQ: CLLS) , a clinical-stage biopharmaceutical company that specializes in oncology, rose 22.7% this week, according to data from S&P Global Market Intelligence . The stock closed last Friday at $3.17, then opened Monday at $3.19. It reached its hig...
-
NEW YORK, May 16, 2022 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, today will present its first research...